RxSight (RXST) CEO pay: -$2.2M in FY2025 after Item 402(v) adjustments
$RXST · RxSight, Inc.Data through FY2025 — latest proxy filed 2026-04-28, checked for new filings 2026-08-21. Every number links to its source.
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2022 | Same, peer group since FY2022 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $4.7M | -$2.2M | -$1.3M | $92.62 | $76.03 | -$38.9M |
| 2024 | $7.0M | $5.1M | $4.2M | $305.60 | $76.22 | -$27.5M |
| 2023 | $3.1M | $11.8M | $6.3M | $358.40 | $72.30 | -$48.6M |
| 2022 | $1.0M | $1.2M | $762,518 | $112.62 | $76.64 | -$66.8M |
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
Frequently asked
How much did the RXST CEO make in 2025?
-$2,156,420 in Compensation Actually Paid (CAP) as RxSight, Inc.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-04-28. CAP is negative here: Item 402(v) adjustments to prior-year equity and pension values exceeded the year's reported total. It is an SEC-defined fair-value measure, not an amount repaid.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on RXST: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary